At a Glance
Acromegaly is a rare chronic endocrine disorder caused by the hypersecretion of growth hormone (GH) from the anterior pituitary gland in adults. A GH-secreting adenoma of the pituitary gland is the most common cause of acromegaly. Rarely, GH may be secreted by some malignancies.
Acromegaly is indolent with symptoms often preceding diagnosis by several years. Visual field defects and persistent headaches are common complaints caused by expansion of the adenoma. The tumor may also compromise normal pituitary tissue leading to deficiencies of other pituitary hormones.
Because GH stimulates the hepatic synthesis of insulin-like growth factor 1 (IGF-1), other symptoms of acromegaly are related to the excess GH and IGF-1 secretion and include:
Enlargement of the extremities
Increase in ring and/or shoe size
Coarsening of facial features
Prognathism (growth of mandible)
Acromegalics have an increased risk of developing diabetes mellitus, hypertension, cardiovascular disease, and congestive heart failure. They also show a greater incidence of premalignant colon polyps that increases the risk of colon cancer.
What Tests Should I Request to Confirm My Clinical Dx? In addition, what follow-up tests might be useful?
GH and IGF-1 testing is indicated for individuals with headaches and musculoskeletal growth. Because GH secretion is pulsatile, its concentration in acromegaly may be within the established reference interval. In contrast, serum concentrations of IGF-1 are relatively constant and are usually elevated in acromegaly. Thus, IGF-1 is the best single test for diagnosis. Acromegaly is excluded, if the GH concentration is less than 0.3 ng/mL in conjunction with a concentration of IGF-1 within the established reference interval.
GH secretion is inhibited by glucose. Individuals with active acromegaly are unable to suppress GH concentration after an oral glucose tolerance test. After administering 75 grams of glucose, samples are obtained over 120 minutes. Failure to suppress GH (<0.3 ng/mL) at 120 minutes is diagnostic of acromegaly. If GH is suppressed, then acromegaly is excluded.
Are There Any Factors That Might Affect the Lab Results? In particular, does your patient take any medications - OTC drugs or Herbals - that might affect the lab results?
Age- and gender-specific reference intervals are required for accurate interpretation of IGF-1. Starvation, obesity, and diabetes mellitus decrease and pregnancy increases concentrations of IGF-1.
Copyright © 2017, 2013 Decision Support in Medicine, LLC. All rights reserved.
No sponsor or advertiser has participated in, approved or paid for the content provided by Decision Support in Medicine LLC. The Licensed Content is the property of and copyrighted by DSM.
Next Article in LabMed
Neurology Advisor Articles
- Clarifying Cardiovascular Risk in Migraine
- Parkinson Disease Symptom Fluctuations Well-Managed With Adaptive Deep Brain Stimulation
- More Evidence Supports Benefits of Cannabidiol for Treatment-Resistant Epilepsy
- Monthly Erenumab Reduces Frequency of Episodic Migraine
- Reduced Risk for Multiple Sclerosis Linked to Greater Sun Exposure
- Tamsulosin Associated With Dementia Risk in Older Patients With BPH
- FDA Approves Blood Test to Assess Concussion
- Gait Difficulty in Parkinson Disease May Be Associated With More Progressive Disease Course
- Tau PET a Useful Biomarker for Alzheimer Disease Risk and Progression
- Multiple Sclerosis Drug Zinbryta Withdrawn From the Market
- Incidence of Delayed Traumatic Intracranial Hemorrhage Low in Older Adults With Blunt Head Trauma
- Older Epilepsy Patients More Likely to Experience AED, Non-AED Drug Interaction
- Female Gender, Natalizumab Exposure Associated With Increased Lymphopenia Risk in FNG-Treated MS
- Accelerated Cognitive Decline Associated With Retinopathy
- Treatment Effects Often Exaggerated in Early Clinical Studies